![]() Tell your doctor if you have or have ever had slowed breathing or asthma. Your doctor will monitor you carefully during your treatment. Hydrocodone may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment and any time your dose is increased. Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-HELP. Talk to your healthcare provider immediately and ask for guidance if you think that you have an opioid addiction or call the U.S. There is a greater risk that you will overuse a hydrocodone combination product if you have or have ever had any of these conditions. Tell your doctor if you or anyone in your family drinks or has ever drunk large amounts of alcohol, uses or has ever used street drugs, or has overused prescription medications, or has had an overdose, or if you have or have ever had depression or another mental illness. While taking hydrocodone combination products, discuss with your healthcare provider your pain treatment goals, length of treatment, and other ways to manage your pain. Do not take more of it, take it more often, or take it in a different way than directed by your doctor. ![]() Take your hydrocodone combination product exactly as directed. ![]() Hydrocodone combination products may be habit forming. Other changes will also be required in various other sections of the prescribing information to educate clinicians, patients, and caregivers about the risks of these drugs.Information in the boxed warning for all IR and ER/LA opioid pain medicines will be updated and reordered to elevate the importance of warnings concerning life-threatening respiratory depression, and risks associated with using opioid pain medicines in conjunction with benzodiazepines or other medicines that depress the central nervous system (CNS).This includes information describing the symptoms that differentiate OIH from opioid tolerance and withdrawal. A new warning is being added about opioid-induced hyperalgesia (OIH) for both IR and ER/LA opioid pain medicines.Updates to the ER/LA opioids recommend that these drugs be reserved for severe and persistent pain requiring an extended period of treatment with a daily opioid pain medicine and for which alternative treatment options are inadequate.Updates to the IR opioids state that these drugs should not be used for an extended period unless the pain remains severe enough to require an opioid pain medicine and alternative treatment options are insufficient, and that many acute pain conditions treated in the outpatient setting require no more than a few days of an opioid pain medicine.The changes apply to both immediate-release (IR) and extended-release/long-acting preparations (ER/LA). The changes are being made to provide additional guidance for safe use of these drugs while also recognizing the important benefits when used appropriately. As part of its ongoing efforts to address the nation's opioid crisis, FDA is requiring several updates to the prescribing information of opioid pain medicines.We are in close contact with Philips Respironics and are awaiting further updates and action steps from Philips Respironics and/or the FDA. ![]() We understand that this is difficult news for many of our valued customers. Please know that Norco is focused on your safety, health and wellbeing. You may also review this video for the proper procedure for registering recalled Philips Respironics devices. Philips has advised of potential health risks related to sound abatement foam used in the above mentioned devices and gives further information on potential impacts to patient health and possible health risks.įor more information, a detailed explanation of which devices are affected, next steps and FAQ’s please refer to the Philips Respironics website by clicking here: or by calling Philips Respironics at (877) 907-7508. only) / field safety notice (Outside of U.S.) affecting specific Philips Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators. Philips Respironics has issued a voluntary medical device recall notification (U.S. Attention patients using Philips Respironics CPAP, BiPAP, and Ventilation devices ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |